One of the most promising is its cardiovascular disease therapy candidate CTX310, a single-treatment gene therapy that has ...

CRISPR Therapeutics' CASGEVY gene-editing therapy targets severe SCD and TDT. Click here to read why CRSP stock is rated as a Buy.

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 10:45 AM ESTCompany ParticipantsSamarth Kulkarni - CEO ...

EDEN (short for environmentally-derived evolutionary network) processes evolutionary DNA from more than one million newly ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

During her postdoctoral fellowship at Harvard’s Wyss Institute, Professor Nicole Weckman (ISTEP, ChemE) developed a new technique to rapidly detect antimicrobial resistant genes in a pathogenic fungus ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Plus: Grok is restricting its image-generating function to paid subscribers only This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the ...

From talking computers to self-driving cars, here are the trends to watch. By Brian X. Chen Brian X. Chen is The Times’s lead consumer technology writer and the author of Tech Fix, a column about the ...